In an Australian study, involving 1472 patients with LEAD, it was shown that the level of Lp(a) ≥ 30 mg/dL was associated with the frequency of peripheral revascularization; however, no association was found between elevated Lp(a) level and the frequency of myocardial infarction, stroke, and death [16]. The gene discussed is LPA; the disease is stroke disorder.